Drugs that contain Beclomethasone Dipropionate

1. List of Qnasl drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7780038 TEVA BRANDED PHARM Dispensing apparatus with dosage counter
Jan, 2027

(3 years from now)

US10188811 TEVA BRANDED PHARM Nasal spray device
Oct, 2031

(8 years from now)

Market Authorisation Date: 23 March, 2012

Treatment: NA

Dosage: AEROSOL, METERED;NASAL

More Information on Dosage

2. List of Qvar 40 drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10695512 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(8 years from now)

US10022510 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(8 years from now)

US10022509 TEVA BRANDED PHARM Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(8 years from now)

US9463289 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(8 years from now)

US10086156 TEVA BRANDED PHARM Dose counter for inhaler and method for counting doses
May, 2031

(8 years from now)

US9808587 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(8 years from now)

US11395889 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(8 years from now)

US10561808 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(8 years from now)

Market Authorisation Date: 15 September, 2000

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

How can I launch a generic of QVAR 40 before it's patent expiration?
More Information on Dosage

3. List of Qvar Redihaler drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8132712 NORTON WATERFORD Metered-dose inhaler
Sep, 2028

(5 years from now)

US10022510 NORTON WATERFORD Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(8 years from now)

US10086156 NORTON WATERFORD Dose counter for inhaler and method for counting doses
May, 2031

(8 years from now)

US10022509 NORTON WATERFORD Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(8 years from now)

US10695512 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(8 years from now)

US11395889 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(8 years from now)

US8931476 NORTON WATERFORD Inhaler
Jul, 2031

(8 years from now)

US10561808 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(8 years from now)

US11395888 NORTON WATERFORD Inhalers and related methods
Jan, 2038

(14 years from now)

US10792447 NORTON WATERFORD Breath actuated inhaler
Jan, 2039

(15 years from now)

Market Authorisation Date: 03 August, 2017

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic